Your browser doesn't support javascript.
loading
The Astonishing Accomplishment of Biological Drug Delivery using Lipid Nanoparticles: An Ubiquitous Review.
Kapoor, Devesh; Chilkapalli, Shirisha C; Prajapati, Bhupendra G; Rodriques, Paul; Patel, Ravish; Singh, Sudarshan; Bhattacharya, Sankha.
Affiliation
  • Kapoor D; Department of Pharmaceutical Technology, Dr. Dayaram Patel Pharmacy College, Bardoli 394601, Gujarat, India.
  • Chilkapalli SC; Department of Pharmaceutical Technology, Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Mehsana-384012, Gujarat, India.
  • Prajapati BG; Department of Pharmaceutical Technology, Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Mehsana-384012, Gujarat, India.
  • Rodriques P; Department of Pharmaceutical Technology, Krishna School of Pharmacy and Research, KPGU, Vadodara, Mumbai NH#8, Varnama, Vadodara, Gujarat, India.
  • Patel R; Department of Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa 388 421, Anand, Gujarat, India.
  • Singh S; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Bhattacharya S; Department of Pharmaceutics, School of Pharmacy & Technology Management, SVKM's NMIMS Deemed-to-be University, Shirpur, Maharashtra 425405, India.
Curr Pharm Biotechnol ; 25(15): 1952-1968, 2024.
Article in En | MEDLINE | ID: mdl-38265380
ABSTRACT
Biotech drugs, including proteins, hormones, enzymes, DNA/RNA therapies, and cell-based treatments, are gaining popularity due to their effectiveness. However, effective delivery systems are needed to overcome administration challenges. Lipid nanoparticles (LNPs) have emerged as promising carriers for various therapies. LNPs are biocompatible, less likely to cause adverse reactions, and can stabilize delicate biological drugs, enhancing their stability and solubility. Scalable and cost-effective manufacturing processes make LNPs suitable for largescale production. Despite recent research efforts, challenges in stability, toxicity, and regulatory concerns have limited the commercial availability of LNP-based products. This review explores the applications, administration routes, challenges, and future directions of LNPs in delivering biopharmaceuticals.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Lipids Limits: Animals / Humans Language: En Journal: Curr Pharm Biotechnol Journal subject: BIOTECNOLOGIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: India Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Lipids Limits: Animals / Humans Language: En Journal: Curr Pharm Biotechnol Journal subject: BIOTECNOLOGIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: India Country of publication: Netherlands